01
BRO
bronchogen
Peptide

bronchogen

Bronchogen is a bioregulator peptide developed in Russia, specifically targeting bronchial and lung tissue. It belongs to the Khavinson peptide family and is used to support respiratory function and promote lung tissue regeneration.

Purity Rating
55% Positive

Lab Notes — Research Studies

01 Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability

Study found that bronchogen increases DNA melting temperature, acting as a stabilizing agent.

View Study ((PubMed))
02 Short Exogenous Peptides Regulate Expression of CLE, KNOX1, and GRF Family Genes in Nicotiana tabacum

Short peptides including bronchogen significantly influence tobacco plant cell culture growth at very low concentrations.

View Study ((PubMed))
03 Peptides tissue-specifically stimulate cell differentiation during their aging

Certain short peptides boost differentiation marker expression in human embryonic fibroblasts, suggesting geroprotective potential.

View Study ((PubMed))
04 Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with DNA

Short biologically active peptides penetrate animal cell nuclei and interact with DNA and RNA.

View Study ((PubMed))
05 Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology

One-month bronchogen therapy in rats reversed structural damage from COPD, restoring bronchial epithelium immune and barrier functions.

View Study ((Research Institute of Pulmonology))

Formula — Benefits & Dosage

⚗️ Effects

  • Limited Western Data: Most research comes from Russian sources.
  • Subtle Effects: Benefits may be gradual and subtle.
  • Best for Chronic Conditions: Most reports involve chronic respiratory issues.

💉 Dosage & Administration

  • Typical Protocol: 1-2 capsules daily for 10-30 days.
  • Cycling: Often used in cycles with breaks between courses.

⚠️ Side Effects

  • Generally Safe: Few side effects reported.
  • Limited Data: Long-term safety not extensively studied.

📦 Availability & Sourcing

  • Russian Suppliers: Primarily available from Russian peptide suppliers.
  • Specialized Retailers: Some international nootropic vendors carry it.

Reaction Log — User Experiences

Limited user reports available. Those with respiratory conditions report some improvements, but evidence is primarily from Russian research.

Synthesis — Related Compounds

⚠️ IMPORTANT DISCLAIMER

This information is for educational and research purposes only. bronchogen may not be approved for human use. Always consult a qualified healthcare professional before using any supplements or research compounds. We do not guarantee accuracy or completeness of information presented.